跳至主要内容
临床试验/ITMCTR2000003227
ITMCTR2000003227尚未招募未知

Regulation of DNA methylation modification of Mesenchymal Stem Cells by Kidney-marrow Simultaneous Therapy in the treatment of osteoarthritis

First affiliated hospital of Zhejiang Chinese Medical University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1. Western medicine diagnosis: in 2018, the Chinese society of bone sciences revised the KOA clinical diagnostic criteria;
  • 2. The average age of KOA patients was between 55 and 75 years old and required knee replacement.

排除标准

  • 1. With other diseases affecting bone metabolism;
  • 2. With rheumatoid diseases, such as systemic diseases, spondylitis or rheumatoid arthritis;
  • 3. With a history of severe joints.

研究者

发起方
First affiliated hospital of Zhejiang Chinese Medical University

相似试验